Literature DB >> 30114663

Fasciculation intensity and disease progression in amyotrophic lateral sclerosis.

Jun Tsugawa1, Thanuja Dharmadasa1, Yan Ma1, William Huynh1, Steve Vucic1, Matthew C Kiernan2.   

Abstract

OBJECTIVE: To investigate the association between the frequency and intensity of fasciculations with clinical measures of disease progression in amyotrophic lateral sclerosis (ALS).
METHODS: Twenty-four consecutive patients with ALS underwent clinical review and neuromuscular ultrasound assessment to detect intensity of fasciculations. Results were correlated with clinical markers of disease severity, as measured by the ALS Functional Rating Scale-revised (ALSFRS-R) and rate of disease progression (ΔFS), in addition to assessment of cortical motor function.
RESULTS: Disease duration negatively correlated (R = -0.530, p < 0.01) with fasciculation intensity, while the ΔFS positively correlated with the fasciculation number (R = 0.626, p < 0.01). In terms of potential central contributions to ectopic impulse generation, patients were classified into cohorts based on their fasciculation intensity and short interval intracortical inhibition (SICI). ΔFS was significantly higher in patients with established hyperexcitability (low SICI) with high fasciculation intensity compared to those patients with minimal SICI change.
CONCLUSIONS: Fasciculation intensity appears linked to disease progression and separately to markers of cortical dysfunction, specifically the advent of cortical hyperexcitability. SIGNIFICANCE: Assessment of the intensity of patient fasciculations is a noninvasive approach that may provide further insight disease pathophysiology in ALS.
Copyright © 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Disease progression rate; Fasciculation; Neuromuscular ultrasound; Short interval intracortical inhibition

Mesh:

Year:  2018        PMID: 30114663     DOI: 10.1016/j.clinph.2018.07.015

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  6 in total

1.  Fasciculation score: a sensitive biomarker in amyotrophic lateral sclerosis.

Authors:  Jing Ma; Qi Wen; Xiaomin Pang; Shan Huang; Jing Zhang; Juan Wang; Xueli Chang; Junhong Guo; Wei Zhang
Journal:  Neurol Sci       Date:  2021-03-11       Impact factor: 3.307

2.  Foreground Detection Analysis of Ultrasound Image Sequences Identifies Markers of Motor Neurone Disease across Diagnostically Relevant Skeletal Muscles.

Authors:  Kate Bibbings; Peter J Harding; Ian D Loram; Nicholas Combes; Emma F Hodson-Tole
Journal:  Ultrasound Med Biol       Date:  2019-03-08       Impact factor: 2.998

3.  Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis.

Authors:  Stephanie L Barnes; Neil G Simon
Journal:  Degener Neurol Neuromuscul Dis       Date:  2019-07-16

4.  Primary lateral sclerosis: consensus diagnostic criteria.

Authors:  Martin R Turner; Richard J Barohn; Philippe Corcia; John K Fink; Matthew B Harms; Matthew C Kiernan; John Ravits; Vincenzo Silani; Zachary Simmons; Jeffrey Statland; Leonard H van den Berg; Hiroshi Mitsumoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-02-06       Impact factor: 10.154

5.  Progressive spastic tetraplegia and axial hypotonia (STAHP) due to SOD1 deficiency: is it really a new entity?

Authors:  Paulo Victor Sgobbi de Souza; Wladimir Bocca Vieira de Rezende Pinto; Igor Braga Farias; Bruno de Mattos Lombardi Badia; Icaro França Navarro Pinto; Gustavo Carvalho Costa; Carolina Maria Marin; Ana Carolina Dos Santos Jorge; Emília Correia Souto; Paulo de Lima Serrano; Roberta Ismael Lacerda Machado; Marco Antônio Troccoli Chieia; Enrico Bertini; Acary Souza Bulle Oliveira
Journal:  Orphanet J Rare Dis       Date:  2021-08-11       Impact factor: 4.123

Review 6.  Muscle ultrasound: Present state and future opportunities.

Authors:  Juerd Wijntjes; Nens van Alfen
Journal:  Muscle Nerve       Date:  2020-10-13       Impact factor: 3.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.